Search clinical trials for: Daratumumab
Total 314 results
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Marc L Gordon, MDJanssen Scientific Affairs, LLCCompletedAlzheimer DiseaseUnited States
-
Hoffmann-La RocheCompletedMultiple MyelomaUnited States, Australia, United Kingdom
-
University of ArkansasJanssen Scientific Affairs, LLCRecruiting
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma, Primary EffusionUnited States
-
Ostfold Hospital TrustOdense University Hospital; Oslo University Hospital; Haukeland University Hospital and other collaboratorsActive, not recruiting
-
Ronald WittelesCompletedHeart Transplant Failure and Rejection | AllosensitizationUnited States
-
Charite University, Berlin, GermanyJanssen-Cilag G.m.b.H; Labor Berlin-Charité Vivantes G.m.b.H; Deutsches Rheuma-Forschungszentrum... and other collaboratorsNot yet recruiting
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingHemolytic AnemiaUnited States
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedKidney Transplant Rejection | Antibody-mediated Rejection | AllosensitizationFrance
-
Hoag Memorial Hospital PresbyterianRecruiting
-
Polish Myeloma ConsortiumJanssen-Cilag Ltd.; Bioscience, S.A.Recruiting
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Georgetown UniversityJanssen, LPRecruitingMonoclonal Gammopathy of Undetermined Significance | Peripheral NeuropathyUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
Barry A. BoilsonJanssen Biotech, Inc.Enrolling by invitation
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research ConsortiumRecruitingMultiple MyelomaUnited States
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
BiocadRecruitingMultiple MyelomaRussian Federation
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Gruppo Italiano Malattie EMatologiche dell'AdultoNot yet recruitingT-Lymphocytic Leukemia, Acute
-
Seoul National University HospitalUnknownPlasmacytoma | Multiple Myeloma in Relapse | DaratumumabKorea, Republic of
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
Janssen Research & Development, LLCCompletedLymphomaTaiwan, China, Singapore, Korea, Republic of, Hong Kong
-
Janssen Research & Development, LLCApproved for marketing
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-CellUnited States, Australia, France, Belgium, Turkey, Netherlands, Korea, Republic of
-
M.D. Anderson Cancer CenterJanssen-Cilag div. of Johnson&Johnson SEWithdrawnProstate Cancer | Malignant Neoplasms of Male Genital Organs
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCWithdrawnMalignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Institute of Hematology & Blood Diseases Hospital...Sinocelltech Ltd.RecruitingHemophilia A With InhibitorChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingAplastic Anemia | Platelet Transfusion RefractorinessChina
-
Mayo ClinicRecruitingProliferative Glomerulonephritis With Monoclonal IgG DepositsUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingNewly Diagnosed Multiple Myeloma
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsActive, not recruitingSmoldering Multiple Myeloma | Monoclonal GammopathyUnited States
-
University Medical Center GroningenHuman Genome Sciences Inc.CompletedAdvanced Cervical CancerNetherlands
-
Thomas LundCompletedMultiple MyelomaDenmark
-
Johnson & Johnson Private LimitedCompleted
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy